AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- Fiserv president resigns, interim leaders named for financial unit
- Nasdaq sinks as AI worries hit chipmakers
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- GameStop stockholders approve share count increase to 2.5 billion
AngioDynamics (ANGO) PT Raised to $13 at Oppenheimer
July 16, 2024 3:27 PM EDTOppenheimer analyst Steven M. Lichtman raised the price target on AngioDynamics (NASDAQ: ANGO) to $13.00 (from $12.00) while maintaining a Outperform rating.
The analyst comments "ANGO's F4Q24 sales of $71.1M (+1.9% y/y pro forma) were in line with the key higher margin/growth... More
